How Ozempic Lowers Blood Sugar
Ozempic (semaglutide) is a GLP-1 receptor agonist injected weekly to treat type 2 diabetes. It reduces blood sugar by stimulating insulin release, slowing gastric emptying, and suppressing glucagon after meals, with effects peaking 1-3 days post-injection.[1]
Duration of Effect After One Dose
A single 1 mg dose lowers fasting blood glucose for up to 7-10 days and postprandial glucose for about 5-7 days, aligning with its half-life of ~1 week. Steady-state effects build over 4-5 weekly doses, providing consistent 24/7 control thereafter.[1][2]
What Happens Between Doses
Blood sugar control remains stable through the weekly interval for most patients on maintenance doses (0.5-2 mg). HbA1c drops 1-2% over 3-6 months, reflecting sustained impact. If a dose is missed by 5 days, effects weaken, raising glucose levels.[2][3]
Factors Affecting Duration
- Dose: Higher doses (e.g., 2 mg) extend control longer than 0.25 mg starter doses.
- Patient variables: Faster effects fade in those with higher BMI or poor adherence; kidney issues may prolong half-life.
- Diet/exercise: High-carb meals can shorten post-meal benefits.[3][4]
Comparisons to Other GLP-1 Drugs
| Drug | Weekly Dose Effect Duration | Half-Life |
|------|-----------------------------|-----------|
| Ozempic (semaglutide) | 7-10 days | ~7 days |
| Trulicity (dulaglutide) | 5-7 days | ~5 days |
| Victoza (liraglutide, daily) | 24 hours | ~13 hours |
| Mounjaro (tirzepatide) | 7+ days (dual action) | ~5 days |
Ozempic outperforms dailies in duration, aiding adherence.[2][4]
When Effects Wear Off Long-Term
Discontinuation leads to blood sugar rebound within 1-2 weeks as insulin sensitivity normalizes. Long-term use (beyond 1 year) maintains effects if dosed consistently, but weight regain can indirectly raise glucose.[3]
[1]: https://www.ozempic.com/content/files/ozempic-USPI.pdf
[2]: Novo Nordisk clinical trials (NEJM 2018; STEP trials)
[3]: ADA guidelines on GLP-1s (Diabetes Care 2023)
[4]: FDA label for Ozempic